Trulieve Cannabis Corp.

  • Market Cap: Small Cap
  • Industry: Other Agricultural Products
  • ISIN: CA89788C1041
CAD
8.70
0.14 (1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

127.61 k

Shareholding (Dec 2025)

FII

0.10%

Held by 14 FIIs

DII

99.9%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Dec 24

  • PRE-TAX PROFIT(Q) At CAD -19.3 has Fallen at -191.35%
  • NET PROFIT(Q) At CAD -83.35 MM has Fallen at -61.71%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 64.75%
2

Risky -

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 1,646 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

-8.95%

stock-summary
Price to Book

1.03

Revenue and Profits:
Net Sales:
409 Million
(Quarterly Results - Dec 2025)
Net Profit:
-63 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.89%
0%
-26.89%
6 Months
-14.37%
0%
-14.37%
1 Year
49.74%
0%
49.74%
2 Years
-46.2%
0%
-46.2%
3 Years
4.07%
0%
4.07%
4 Years
-65.49%
0%
-65.49%
5 Years
-86.7%
0%
-86.7%

Trulieve Cannabis Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.80%
EBIT Growth (5y)
36.19%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
1.07
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.67
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
16.66%
ROE (avg)
3.00%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.03
EV to EBIT
7.73
EV to EBITDA
3.62
EV to Capital Employed
1.03
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.38%
ROE (Latest)
-8.95%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 14 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.00% vs -5.12% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -91.74% vs -49.32% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "408.80",
          "val2": "396.90",
          "chgp": "3.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.70",
          "val2": "122.00",
          "chgp": "-25.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "20.50",
          "val2": "22.20",
          "chgp": "-7.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.70",
          "val2": "-4.10",
          "chgp": "-258.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-62.70",
          "val2": "-32.70",
          "chgp": "-91.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.00%",
          "val2": "156.90%",
          "chgp": "-8.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.54% vs 6.65% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.19% vs 63.93% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,650.40",
          "val2": "1,625.40",
          "chgp": "1.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "464.20",
          "val2": "369.70",
          "chgp": "25.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "88.70",
          "val2": "85.20",
          "chgp": "4.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-27.60",
          "val2": "-17.70",
          "chgp": "-55.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-163.00",
          "val2": "-212.20",
          "chgp": "23.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.40%",
          "val2": "87.20%",
          "chgp": "4.72%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
408.80
396.90
3.00%
Operating Profit (PBDIT) excl Other Income
90.70
122.00
-25.66%
Interest
20.50
22.20
-7.66%
Exceptional Items
-14.70
-4.10
-258.54%
Consolidate Net Profit
-62.70
-32.70
-91.74%
Operating Profit Margin (Excl OI)
73.00%
156.90%
-8.39%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.00% vs -5.12% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -91.74% vs -49.32% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,650.40
1,625.40
1.54%
Operating Profit (PBDIT) excl Other Income
464.20
369.70
25.56%
Interest
88.70
85.20
4.11%
Exceptional Items
-27.60
-17.70
-55.93%
Consolidate Net Profit
-163.00
-212.20
23.19%
Operating Profit Margin (Excl OI)
134.40%
87.20%
4.72%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.54% vs 6.65% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 23.19% vs 63.93% in Dec 2024

stock-summaryCompany CV
About Trulieve Cannabis Corp. stock-summary
stock-summary
Trulieve Cannabis Corp.
Other Agricultural Products
Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts and Connecticut. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates a 35,000 square foot cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.
Company Coordinates stock-summary
Company Details
6749 Ben Bostic Rd , QUINCY FL : 32351-9121
stock-summary
Tel: 1 850 50802611 850 4807955
stock-summary
stock-summary
Registrar Details